- Investing Ideas
- /
- Pakistani Pharmaceuticals & Biotech Potentially Undervalued Companies
Pakistani Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
5
Companies with a Value score of at least 3, ordered by Value score
5 companies
Hoechst Pakistan
Market Cap: PK₨40.6b
Engages in the manufacture, trading, and sale of pharmaceutical and related products in Pakistan, Afghanistan, and internationally.
HPL
PK₨4,214.41
7D
2.8%
1Y
60.2%
Otsuka Pakistan
Market Cap: PK₨4.1b
Manufactures, markets, and distributes intravenous infusions in Pakistan and Afghanistan.
OTSU
PK₨342.95
7D
3.6%
1Y
120.5%
GlaxoSmithKline Pakistan
Market Cap: PK₨123.6b
Operates as a biopharma company in Pakistan.
GLAXO
PK₨388.26
7D
-1.8%
1Y
19.3%
AGP
Market Cap: PK₨51.5b
Manufactures, sells, wholesales, distributes, exports, imports, markets, deals in pharmaceutical and healthcare products in Pakistan and Afghanistan.
AGP
PK₨183.77
7D
-1.4%
1Y
12.5%
Ferozsons Laboratories
Market Cap: PK₨17.4b
Engages in the importing, manufacturing, and sale of pharmaceutical products and medical devices in Pakistan, Afghanistan, Sri Lanka, the Philippines, Kenya, Myanmar, Kyrgyzstan, Mongolia, Cambodia, and internationally.
FEROZ
PK₨400.34
7D
-0.2%
1Y
21.3%